The pill with AD 30 imprinted is orange, round and has been identified as Adderall 30 mg.
It is provided by Shire US Inc.

Adderall for adhd;
Narcolepsy belongs to the central nervous system drug stimulant.
Risks cannot be ruled out during pregnancy.
Adderall 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substances Act (CSA).

Adderall
Generic name: amphetamine/dextroamphetamine
Version description: AD 30
Dose: 30 mg
It’s orange
Shape: Round
Size: 10.00 mm

Drug class: Central nervous system stimulant
Category of pregnancy: C – Risks cannot be excluded
CSA schedule: 2 — High potential for abuse
National Drug Regulations (NDC) : 54092-0377
Label/supplier: Shire US Inc.

Description:

Adderall is a prescription medication that contains a combination of two central nervous system stimulants: amphetamine and dextroamphetamine. It is commonly used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. Adderall works by affecting the levels of certain neurotransmitters in the brain, leading to increased focus, attention, and impulse control in individuals with ADHD.

Key Points:

• Active Ingredients:
  • Amphetamine: A powerful stimulant that affects neurotransmitters in the brain.
  • Dextroamphetamine: A more specific form of amphetamine.
• Indications:
  • ADHD: Adderall is FDA-approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in both children and adults.
  • Narcolepsy: It is also used to manage narcolepsy, a sleep disorder characterized by excessive daytime sleepiness and sudden episodes of sleep.
• Mechanism of Action:
  • Adderall increases the levels of neurotransmitters, such as dopamine and norepinephrine, in the brain. These chemicals play a role in attention, focus, and impulse control.
• Dosage Forms:
  • Adderall is available in both immediate-release (IR) and extended-release (XR) formulations. The extended-release version provides a more gradual and sustained release of the medication over time.
• Dosage and Administration:
  • Dosage is individualized based on the patient’s response and needs. It is usually taken orally, with or without food.
  • The extended-release form is typically taken once daily in the morning, while immediate-release forms may need to be taken multiple times a day.
• Monitoring:
  • Patients taking Adderall should be regularly monitored by healthcare providers to assess the medication’s effectiveness and any potential side effects.
• Side Effects:
  • Common side effects may include insomnia, decreased appetite, weight loss, increased heart rate, and nervousness.
  • Serious side effects are rare but may include cardiovascular issues, psychiatric symptoms, and growth suppression in children.
• Precautions:
  • Adderall has a potential for abuse due to its stimulant properties. It should be used cautiously in individuals with a history of substance abuse.
  • It is important for healthcare providers to be aware of the patient’s medical history, including cardiovascular issues, mental health conditions, and any potential drug interactions.
• Patient Education:
  • Patients should be educated on the proper use of Adderall, including dosage instructions, potential side effects, and the importance of regular follow-up with healthcare providers.
• Legal Status:
  • Adderall is a Schedule II controlled substance, indicating a recognized medical use but a potential for abuse and dependence.

It’s crucial for individuals to take Adderall only under the supervision of a qualified healthcare professional, and any concerns or side effects should be promptly reported to the prescribing doctor. Additionally, the medication should be stored securely to prevent unauthorized use.